Mutations in multiple genes, (GABRA1, GABRB2 and GABRG2), have a common target (α1β2γ2 GABAA receptors) to cause Dravet syndrome. The gene discussed is GABRA1; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.